on Texas Cardiac Arrhythmia Institute At St. David's Medical Center
Texas Cardiac Arrhythmia Institute Pioneers New Cardiac Treatment Trial
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin is the first U.S. institution to join a clinical trial for an innovative mapping and pulsed field ablation system. This system aims to treat paroxysmal and persistent atrial fibrillation, guided by Dr. Andrea Natale. Atrial fibrillation affects millions globally and carries risks of severe complications.
The novel system uses electric fields to ablate heart tissue, minimizing risks to surrounding structures compared to traditional methods using extreme temperatures. The system's advanced 3D cardiac mapping offers detailed visualization of the heart’s electrical activity, enhancing procedure precision.
TCAI's participation underscores its leadership in arrhythmia care and technology advancement, essential for the future of electrophysiology.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Texas Cardiac Arrhythmia Institute At St. David's Medical Center news